Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Pantaleo: RepliVax Vaccine Platform |
| Strategy: | Combo: DNA, protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2015-06-10 |
| Study Made Public: | 2017-07-27 |
Title
RepliVax Immunogenicity NHP Pilot Study
Description
CAVD 498 is a non-human primate study comparing protein, DNA, NYVAC, and RepliVax prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
MF59 gp120 C.1086 gp120 TV1 DNA-HIV-PT123 NYVAC-HIV-PT1 NYVAC-HIV-PT4 RepliVaxIntegrated data
BAMA, ICS, NAb
Non-integrated data
No non-integrated data is available for this study.